| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ESMO Minimal Clinical Recommendations for diagnosis, treatment and follow-up of esophageal cancer
|
Stahl, M.
|
|
|
16 |
S1 |
p. i26-i27
|
artikel
|
| 2 |
ESMO Minimum Clinical Recommendations: assuring common standards of care
|
Stahel, R.A.
|
|
|
16 |
S1 |
p. i5-i6
|
artikel
|
| 3 |
ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer
|
Van Cutsem, E.J.D.
|
|
|
16 |
S1 |
p. i16-i17
|
artikel
|
| 4 |
ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer
|
Pestalozzi, B.C.
|
|
|
16 |
S1 |
p. i7-i9
|
artikel
|
| 5 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of advanced colorectal cancer
|
Van Cutsem, E.J.D.
|
|
|
16 |
S1 |
p. i18-i19
|
artikel
|
| 6 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)
|
Briasoulis, E.
|
|
|
16 |
S1 |
p. i75-i76
|
artikel
|
| 7 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia
|
Hallek, M.
|
|
|
16 |
S1 |
p. i50-i51
|
artikel
|
| 8 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
|
Jost, L.M.
|
|
|
16 |
S1 |
p. i66-i68
|
artikel
|
| 9 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of epithelial ovarian carcinoma
|
Vasey, P.A.
|
|
|
16 |
S1 |
p. i13-i15
|
artikel
|
| 10 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Ewing's sarcoma of bone
|
Saeter, G.
|
|
|
16 |
S1 |
p. i73-i74
|
artikel
|
| 11 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer
|
Cunningham, D.
|
|
|
16 |
S1 |
p. i22-i23
|
artikel
|
| 12 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease
|
Jost, L.M.
|
|
|
16 |
S1 |
p. i54-i55
|
artikel
|
| 13 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer
|
Kataja, V.V.
|
|
|
16 |
S1 |
p. i43-i44
|
artikel
|
| 14 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC)
|
Kataja, V.V.
|
|
|
16 |
S1 |
p. i10-i12
|
artikel
|
| 15 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma
|
Stupp, R.
|
|
|
16 |
S1 |
p. i64-i65
|
artikel
|
| 16 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumors (NSGCT)
|
Huddart, R.A.
|
|
|
16 |
S1 |
p. i37-i39
|
artikel
|
| 17 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma
|
Harrouseau, J.-L.
|
|
|
16 |
S1 |
p. i45-i47
|
artikel
|
| 18 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma
|
Jost, L.M.
|
|
|
16 |
S1 |
p. i58-i59
|
artikel
|
| 19 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
|
Felip, E.
|
|
|
16 |
S1 |
p. i28-i29
|
artikel
|
| 20 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of osteosarcoma
|
Saeter, G.
|
|
|
16 |
S1 |
p. i71-i72
|
artikel
|
| 21 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer
|
Herrmann, R.
|
|
|
16 |
S1 |
p. i24-i25
|
artikel
|
| 22 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer
|
Kataja, V.V.
|
|
|
16 |
S1 |
p. i34-i36
|
artikel
|
| 23 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer
|
Tveit, K.M.
|
|
|
16 |
S1 |
p. i20-i21
|
artikel
|
| 24 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma
|
Jost, L.M.
|
|
|
16 |
S1 |
p. i60-i61
|
artikel
|
| 25 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)
|
Felip, E.
|
|
|
16 |
S1 |
p. i30-i31
|
artikel
|
| 26 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas
|
Leyvraz, S.
|
|
|
16 |
S1 |
p. i69-i70
|
artikel
|
| 27 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN)
|
Pivot, X.
|
|
|
16 |
S1 |
p. i62-i63
|
artikel
|
| 28 |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of testicular seminoma
|
Huddart, R.A.
|
|
|
16 |
S1 |
p. i40-i42
|
artikel
|
| 29 |
ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
|
Herrstedt, J.
|
|
|
16 |
S1 |
p. i77-i79
|
artikel
|
| 30 |
ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients
|
Fey, M.F.
|
|
|
16 |
S1 |
p. i48-i49
|
artikel
|
| 31 |
ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML)
|
Simonsson, B.
|
|
|
16 |
S1 |
p. i52-i53
|
artikel
|
| 32 |
ESMO Minimum Clinical Recommendations for the management of cancer pain
|
Jost, L.M.
|
|
|
16 |
S1 |
p. i83-i85
|
artikel
|
| 33 |
ESMO recommendations for the application of hematopoietic growth factors
|
Greil, R.
|
|
|
16 |
S1 |
p. i80-i82
|
artikel
|
| 34 |
Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant pleural mesothelioma
|
Manegold, C.
|
|
|
16 |
S1 |
p. i32-i33
|
artikel
|
| 35 |
Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma
|
Hiddemann, W.
|
|
|
16 |
S1 |
p. i56-i57
|
artikel
|
| 36 |
Table of Contents
|
|
|
|
16 |
S1 |
p. ii-iii
|
artikel
|
Tijdschrift beschrijving